Literature DB >> 10600937

Hormone-stimulated Ca2+ transport in rabbit kidney: multiple sites of inhibition by exogenous ATP.

J van Baal1, J G Hoenderop, M Groenendijk, C H van Os, R J Bindels, P H Willems.   

Abstract

Exogenous ATP markedly reduced 1-desamino-8-D-arginine vasopressin (dDAVP)-stimulated Ca2+ transport and cAMP accumulation in primary cultures of rabbit connecting tubule and cortical collecting duct cells. Similarly, ATP inhibited the stimulatory effect of 8-bromo-cAMP. At first sight, this is in agreement with the "classic" concept that dDAVP exerts its stimulatory effect via cAMP. However, dDAVP-stimulated Ca2+ transport was markedly reduced by the protein kinase C (PKC) inhibitor chelerythrine, reported previously to inhibit the cAMP-independent pathway responsible for parathyroid hormone-, [Arg8]vasopressin-, PGE2-, and adenosine-stimulated Ca2+ transport. Chelerythrine also inhibited the increase in Ca2+ transport evoked by the cAMP-independent A1 receptor agonist N6-cyclopentyladenosine (CPA). Downregulation of phorbol ester-sensitive PKC isoforms by chronic phorbol ester treatment has been shown before to be without effect on hormone-stimulated Ca2+ transport, indicating that the chelerythrine-inhibitable pathway consists of a phorbol ester-insensitive PKC isoform. Here, this maneuver did not affect ATP inhibition of dDAVP-stimulated Ca2+ transport and cAMP formation, while abolishing ATP inhibition of CPA-stimulated Ca2+ transport. These findings show that ATP acts via 1) a phorbol ester-sensitive PKC isoform to inhibit hormonal stimulation of Ca2+ transport at the level of the chelerythrine-inhibitable pathway involving a phorbol ester-insensitive PKC isoform and 2) a phorbol ester-insensitive mechanism to inhibit V2 receptor-mediated concomitant activation of this pathway and adenylyl cyclase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600937     DOI: 10.1152/ajprenal.1999.277.6.F899

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Characterization of a Madin-Darby canine kidney cell line stably expressing TRPV5.

Authors:  Els den Dekker; Joost Schoeber; Catalin N Topala; Stan F J van de Graaf; Joost G J Hoenderop; René J M Bindels
Journal:  Pflugers Arch       Date:  2005-05-28       Impact factor: 3.657

Review 2.  TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate.

Authors:  Tom Nijenhuis; Joost G J Hoenderop; René J M Bindels
Journal:  Pflugers Arch       Date:  2005-07-26       Impact factor: 3.657

3.  Calcium transport in human salivary glands: a proposed model of calcium secretion into saliva.

Authors:  Veronika Homann; Evamaria Kinne-Saffran; Wolfgang H Arnold; Peter Gaengler; Rolf K-H Kinne
Journal:  Histochem Cell Biol       Date:  2005-11-04       Impact factor: 4.304

Review 4.  Sensing of tubular flow and renal electrolyte transport.

Authors:  Eric H J Verschuren; Charlotte Castenmiller; Dorien J M Peters; Francisco J Arjona; René J M Bindels; Joost G J Hoenderop
Journal:  Nat Rev Nephrol       Date:  2020-03-03       Impact factor: 28.314

5.  Angiotensin II enhances connecting tubule glomerular feedback.

Authors:  Yilin Ren; Martin A D'Ambrosio; Jeffrey L Garvin; Oscar A Carretero
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

Review 6.  Regulation of renal function and blood pressure control by P2 purinoceptors in the kidney.

Authors:  Justin Van Beusecum; Edward W Inscho
Journal:  Curr Opin Pharmacol       Date:  2015-01-20       Impact factor: 5.547

7.  Effects of extracellular nucleotides on renal tubular solute transport.

Authors:  Matthew A Bailey; David G Shirley
Journal:  Purinergic Signal       Date:  2009-03-24       Impact factor: 3.765

8.  Influence of feeding and UVB exposition on the absorption mechanisms of calcium in the gastrointestinal tract of veiled chameleons (Chamaeleo calyptratus).

Authors:  D Haxhiu; S Hoby; C Wenker; A Boos; M P Kowalewski; F Lewis; A Liesegang
Journal:  J Anim Physiol Anim Nutr (Berl)       Date:  2014-05-22       Impact factor: 2.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.